Fosun: Net profit in the first half of 2025 increased by 140.45% year-on-year.

Fosun Pharma announced that its operating income in the first half of 2025 was 1.476 billion yuan, a year-on-year increase of 62.14%. Net profit was 251 million yuan, a year-on-year increase of 140.45%. Basic earnings per share were 1.59 yuan per share, a year-on-year increase of 144.62%.